Literature DB >> 12819534

Inclusion body myositis: another possible manifestation of antiretroviral-associated mitochondrial toxicity.

Mona R Loutfy, Nancy L Sheehan, John E Goodhew, Sharon L Walmsley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12819534     DOI： 10.1097/01.aids.0000060401.18106.ba

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

1.  Severe myositis on commencement of efavirenz, abacavir and lamivudine, in the absence of lactic acidosis or classical abacavir hypersensitivity.

Authors:  Mirella Jane Parsonage; Gavin Barlow; Patrick Lillie; Peter Moss; Katherine Adams; Hiten Thaker
Journal:  BMJ Case Rep       Date:  2009-06-15

2.  Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.

Authors:  Thomas E Lloyd; Iago Pinal-Fernandez; E Harlan Michelle; Lisa Christopher-Stine; Katherine Pak; Ned Sacktor; Andrew L Mammen
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.